LTRYW
Translational Development Acquisition Corp.
NASDAQ · Consumer Cyclical · Gambling, Resorts & Casinos · US
$0.00
−27.78%Year over year
Reported trailing growth
- Revenue
- +49.2%
- EBITDA
- +24.9%
- EBIT
- -21.7%
- EPS
- +75.7%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +9108.8%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -56.5%
- EBITDA
- +30.7%
- EBIT
- +1.6%
- Net income
- +27.9%
- EPS
- +70.6%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026